FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4149011000001101: Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18030501000001113 Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18030601000001112 Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a Lanreotide 30mg powder and solvent for suspension for injection vials false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has active ingredient Lanreotide acetate false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has active ingredient Lanreotide acetate true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a Lanreotide 30mg powder and solvent for injection suspension vial false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a Somatuline LA true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has specific active ingredient Lanreotide acetate true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Has basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a Lanreotide 30mg powder and solvent for suspension for injection vials false Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a Lanreotide 30mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Is pack of False Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Has AMP True Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start